Additive dominant effect of a SOX10 mutation underlies a complex phenotype of PCWH
Distinct classes of SOX10 mutations result in peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome, and Hirschsprung disease, collectively known as PCWH. Meanwhile, SOX10 haploinsufficiency caused by allelic loss-of-function mutations leads to a milder non...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2015-08-01
|
| Series: | Neurobiology of Disease |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996115001606 |
| _version_ | 1818742148862836736 |
|---|---|
| author | Yukiko Ito Naoko Inoue Yukiko U. Inoue Shoko Nakamura Yoshiki Matsuda Masumi Inagaki Takahiro Ohkubo Junko Asami Youhei W. Terakawa Shinichi Kohsaka Yu-ichi Goto Chihiro Akazawa Takayoshi Inoue Ken Inoue |
| author_facet | Yukiko Ito Naoko Inoue Yukiko U. Inoue Shoko Nakamura Yoshiki Matsuda Masumi Inagaki Takahiro Ohkubo Junko Asami Youhei W. Terakawa Shinichi Kohsaka Yu-ichi Goto Chihiro Akazawa Takayoshi Inoue Ken Inoue |
| author_sort | Yukiko Ito |
| collection | DOAJ |
| description | Distinct classes of SOX10 mutations result in peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome, and Hirschsprung disease, collectively known as PCWH. Meanwhile, SOX10 haploinsufficiency caused by allelic loss-of-function mutations leads to a milder non-neurological disorder, Waardenburg–Hirschsprung disease. The cellular pathogenesis of more complex PCWH phenotypes in vivo has not been thoroughly understood. To determine the pathogenesis of PCWH, we have established a transgenic mouse model. A known PCWH-causing SOX10 mutation, c.1400del12, was introduced into mouse Sox10-expressing cells by means of bacterial artificial chromosome (BAC) transgenesis. By crossing the multiple transgenic lines, we examined the effects produced by various copy numbers of the mutant transgene. Within the nervous systems, transgenic mice revealed a delay in the incorporation of Schwann cells in the sciatic nerve and the terminal differentiation of oligodendrocytes in the spinal cord. Transgenic mice also showed defects in melanocytes presenting as neurosensory deafness and abnormal skin pigmentation, and a loss of the enteric nervous system. Phenotypes in each lineage were more severe in mice carrying higher copy numbers, suggesting a gene dosage effect for mutant SOX10. By uncoupling the effects of gain-of-function and haploinsufficiency in vivo, we have demonstrated that the effect of a PCWH-causing SOX10 mutation is solely pathogenic in each SOX10-expressing cellular lineage in a dosage-dependent manner. In both the peripheral and central nervous systems, the primary consequence of SOX10 mutations is hypomyelination. The complex neurological phenotypes in PCWH patients likely result from a combination of haploinsufficiency and additive dominant effect. |
| first_indexed | 2024-12-18T02:07:55Z |
| format | Article |
| id | doaj.art-3d3bfe4859514db89eb3827407b0bb9a |
| institution | Directory Open Access Journal |
| issn | 1095-953X |
| language | English |
| last_indexed | 2024-12-18T02:07:55Z |
| publishDate | 2015-08-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Neurobiology of Disease |
| spelling | doaj.art-3d3bfe4859514db89eb3827407b0bb9a2022-12-21T21:24:33ZengElsevierNeurobiology of Disease1095-953X2015-08-0180114Additive dominant effect of a SOX10 mutation underlies a complex phenotype of PCWHYukiko Ito0Naoko Inoue1Yukiko U. Inoue2Shoko Nakamura3Yoshiki Matsuda4Masumi Inagaki5Takahiro Ohkubo6Junko Asami7Youhei W. Terakawa8Shinichi Kohsaka9Yu-ichi Goto10Chihiro Akazawa11Takayoshi Inoue12Ken Inoue13Department of Mental Retardation and Birth Defect Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Ogawahigashi, 4-1-1, Kodaira, Tokyo 187-8502, Japan; Department of Molecular Neuroscience, Medical Research Institute, Tokyo Medical and Dental University (TMDU), 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, JapanDepartment of Mental Retardation and Birth Defect Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Ogawahigashi, 4-1-1, Kodaira, Tokyo 187-8502, JapanDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, NCNP, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502, JapanDepartment of Mental Retardation and Birth Defect Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Ogawahigashi, 4-1-1, Kodaira, Tokyo 187-8502, JapanDepartment of Developmental Disorders, National Institute of Mental Health, NCNP, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502, JapanDepartment of Developmental Disorders, National Institute of Mental Health, NCNP, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502, JapanDepartment of Mental Retardation and Birth Defect Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Ogawahigashi, 4-1-1, Kodaira, Tokyo 187-8502, JapanDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, NCNP, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502, JapanDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, NCNP, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502, Japan; Division of Morphological Neuroscience, Gifu University Graduate School of Medicine, 1-1 Yanagito, Gifu, Gifu 501-1194, JapanDepartment of Neurochemistry, National Institute of Neuroscience, NCNP, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502, JapanDepartment of Mental Retardation and Birth Defect Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Ogawahigashi, 4-1-1, Kodaira, Tokyo 187-8502, JapanDepartment of Neurochemistry, National Institute of Neuroscience, NCNP, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502, Japan; Department of Biochemistry and Biophysics, Graduate School of Health Care Sciences, TMDU, 1-5-45 Yushima, Bunkyo-ku, 113-8510 Tokyo, JapanDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, NCNP, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502, JapanDepartment of Mental Retardation and Birth Defect Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Ogawahigashi, 4-1-1, Kodaira, Tokyo 187-8502, Japan; Corresponding author. Fax: +81 42 346 1743.Distinct classes of SOX10 mutations result in peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome, and Hirschsprung disease, collectively known as PCWH. Meanwhile, SOX10 haploinsufficiency caused by allelic loss-of-function mutations leads to a milder non-neurological disorder, Waardenburg–Hirschsprung disease. The cellular pathogenesis of more complex PCWH phenotypes in vivo has not been thoroughly understood. To determine the pathogenesis of PCWH, we have established a transgenic mouse model. A known PCWH-causing SOX10 mutation, c.1400del12, was introduced into mouse Sox10-expressing cells by means of bacterial artificial chromosome (BAC) transgenesis. By crossing the multiple transgenic lines, we examined the effects produced by various copy numbers of the mutant transgene. Within the nervous systems, transgenic mice revealed a delay in the incorporation of Schwann cells in the sciatic nerve and the terminal differentiation of oligodendrocytes in the spinal cord. Transgenic mice also showed defects in melanocytes presenting as neurosensory deafness and abnormal skin pigmentation, and a loss of the enteric nervous system. Phenotypes in each lineage were more severe in mice carrying higher copy numbers, suggesting a gene dosage effect for mutant SOX10. By uncoupling the effects of gain-of-function and haploinsufficiency in vivo, we have demonstrated that the effect of a PCWH-causing SOX10 mutation is solely pathogenic in each SOX10-expressing cellular lineage in a dosage-dependent manner. In both the peripheral and central nervous systems, the primary consequence of SOX10 mutations is hypomyelination. The complex neurological phenotypes in PCWH patients likely result from a combination of haploinsufficiency and additive dominant effect.http://www.sciencedirect.com/science/article/pii/S0969996115001606PCWHMutant SOX10BAC transgenic mouse |
| spellingShingle | Yukiko Ito Naoko Inoue Yukiko U. Inoue Shoko Nakamura Yoshiki Matsuda Masumi Inagaki Takahiro Ohkubo Junko Asami Youhei W. Terakawa Shinichi Kohsaka Yu-ichi Goto Chihiro Akazawa Takayoshi Inoue Ken Inoue Additive dominant effect of a SOX10 mutation underlies a complex phenotype of PCWH Neurobiology of Disease PCWH Mutant SOX10 BAC transgenic mouse |
| title | Additive dominant effect of a SOX10 mutation underlies a complex phenotype of PCWH |
| title_full | Additive dominant effect of a SOX10 mutation underlies a complex phenotype of PCWH |
| title_fullStr | Additive dominant effect of a SOX10 mutation underlies a complex phenotype of PCWH |
| title_full_unstemmed | Additive dominant effect of a SOX10 mutation underlies a complex phenotype of PCWH |
| title_short | Additive dominant effect of a SOX10 mutation underlies a complex phenotype of PCWH |
| title_sort | additive dominant effect of a sox10 mutation underlies a complex phenotype of pcwh |
| topic | PCWH Mutant SOX10 BAC transgenic mouse |
| url | http://www.sciencedirect.com/science/article/pii/S0969996115001606 |
| work_keys_str_mv | AT yukikoito additivedominanteffectofasox10mutationunderliesacomplexphenotypeofpcwh AT naokoinoue additivedominanteffectofasox10mutationunderliesacomplexphenotypeofpcwh AT yukikouinoue additivedominanteffectofasox10mutationunderliesacomplexphenotypeofpcwh AT shokonakamura additivedominanteffectofasox10mutationunderliesacomplexphenotypeofpcwh AT yoshikimatsuda additivedominanteffectofasox10mutationunderliesacomplexphenotypeofpcwh AT masumiinagaki additivedominanteffectofasox10mutationunderliesacomplexphenotypeofpcwh AT takahiroohkubo additivedominanteffectofasox10mutationunderliesacomplexphenotypeofpcwh AT junkoasami additivedominanteffectofasox10mutationunderliesacomplexphenotypeofpcwh AT youheiwterakawa additivedominanteffectofasox10mutationunderliesacomplexphenotypeofpcwh AT shinichikohsaka additivedominanteffectofasox10mutationunderliesacomplexphenotypeofpcwh AT yuichigoto additivedominanteffectofasox10mutationunderliesacomplexphenotypeofpcwh AT chihiroakazawa additivedominanteffectofasox10mutationunderliesacomplexphenotypeofpcwh AT takayoshiinoue additivedominanteffectofasox10mutationunderliesacomplexphenotypeofpcwh AT keninoue additivedominanteffectofasox10mutationunderliesacomplexphenotypeofpcwh |